- KR₩73bn
- KR₩226bn
- KR₩367bn
Annual balance sheet for JC Chemical, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 17,187 | 13,901 | 9,025 | 21,037 | 30,352 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 17,411 | 37,543 | 50,287 | 28,115 | 28,975 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 76,623 | 141,810 | 127,727 | 117,936 | 118,756 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 124,072 | 130,478 | 127,940 | 130,319 | 153,000 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 240,970 | 320,805 | 308,044 | 300,138 | 331,844 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 85,625 | 154,048 | 126,795 | 109,004 | 131,906 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 139,766 | 189,474 | 160,564 | 135,321 | 168,053 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 101,204 | 131,332 | 147,481 | 164,817 | 163,791 |
| Total Liabilities & Shareholders' Equity | 240,970 | 320,805 | 308,044 | 300,138 | 331,844 |
| Total Common Shares Outstanding |